Diabetic ulcer peptide therapy (Issar Pharmaceuticals)
糖尿病溃疡多肽疗法
Report date: 2022/12/17 23:45:54
Base Information
Drug NameDiabetic ulcer peptide therapy (Issar Pharmaceuticals)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIssar Pharmaceuticals
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A